SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-19-017795
Filing Date
2019-09-12
Accepted
2019-09-11 19:52:35
Documents
4
Effectiveness Date
2019-09-12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82019_emmauslife.htm S-8 132357
2 OPINION OF DALE E. SHORT (INCLUDED WITH THIS REGISTRATION STATEMENT) fs82019ex5-1_emmaus.htm EX-5.1 11388
3 CONSENT OF MARCUM LLP fs82019ex23-1_emmaus.htm EX-23.1 2998
4 CONSENT OF SINGERLEWAK LLP fs82019ex23-2_emmaus.htm EX-23.2 3013
  Complete submission text file 0001213900-19-017795.txt   151061
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-233718 | Film No.: 191089313
SIC: 8090 Services-Misc Health & Allied Services, NEC